Difference between revisions of "Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5 (Q9577)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 352, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): A gain-of-function mutation of JAK2 in myeloproliferative disorders, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | A gain-of-function mutation of JAK2 in myeloproliferative disorders (English) | ||
| Property / title: A gain-of-function mutation of JAK2 in myeloproliferative disorders (English) / rank | |||
| + | Normal rank | ||
Revision as of 21:58, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kralovics R, et al. N. Engl. J. Med. (2005) cited as Ref 314 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kralovics R
0 references
2005
0 references
N. Engl. J. Med.
0 references
352
0 references
A gain-of-function mutation of JAK2 in myeloproliferative disorders (English)
0 references
